When to suspect Ebola

Slideshow

  • Consider epidemiologic risk factors such as contact with blood or other body fluids or human remains of a patient known to have or suspected to have EVD or direct handling of bats or non-human primates from disease-endemic areas.

    Epidemiologic risk factors

    Consider epidemiologic risk factors such as contact with blood or other body fluids or human remains of a patient known to have or suspected to have EVD or direct handling of bats or non-human primates from disease-endemic areas.

  • High risk exposures include any of the following: percutaneous (e.g., needle stick) or mucous membrane exposure to blood or body fluids of EVD patient; direct skin contact with, or exposure to blood or body fluids of an EVD patient without appropriate personal protective equipment (PPE); processing blood or body fluids of a confirmed EVD patient without appropriate PPE or standard biosafety precautions; direct contact with a dead body without appropriate PPE in a country where an EVD outbreak is occurring.

    High risk exposures

    High risk exposures include any of the following: percutaneous (e.g., needle stick) or mucous membrane exposure to blood or body fluids of EVD patient; direct skin contact with, or exposure to blood or body fluids of an EVD patient without appropriate personal protective equipment (PPE); processing blood or body fluids of a confirmed EVD patient without appropriate PPE or standard biosafety precautions; direct contact with a dead body without appropriate PPE in a country where an EVD outbreak is occurring.

  • A low risk exposure includes any of the following: household contact with an EVD patient and having direct brief contact (e.g., shaking hands) with an EVD patient while not wearing recommended personal protective equipment.

    Low risk exposures

    A low risk exposure includes any of the following: household contact with an EVD patient and having direct brief contact (e.g., shaking hands) with an EVD patient while not wearing recommended personal protective equipment.

  • Clinicians evaluating a patient under investigation should contact their local or state health departments. Health departments should contact CDC EOC (770)488-7100.

    CDC Contact Information

    Clinicians evaluating a patient under investigation should contact their local or state health departments. Health departments should contact CDC EOC (770)488-7100.

  • Patients who report residence in, or travel to, an area where EVD transmission is active should be examined if they present with other clinical criteria.

    Countries with confirmed EVD transmission

    Patients who report residence in, or travel to, an area where EVD transmission is active should be examined if they present with other clinical criteria.

  • Close contact with EVD patients in health care facilities or community settings. Close contact is defined as being within approximately 3 feet (1 meter) of an EVD patient or within the patient’s room or care area for a prolonged period of time (e.g., health care personnel, household members) while not wearing recommended personal protective equipment (i.e., standard, droplet, and contact precautions).

    What is considered close contact?

    Close contact with EVD patients in health care facilities or community settings. Close contact is defined as being within approximately 3 feet (1 meter) of an EVD patient or within the patient’s room or care area for a prolonged period of time (e.g., health care personnel, household members) while not wearing recommended personal protective equipment (i.e., standard, droplet, and contact precautions).

  • Clinical criteria for Ebola Virus Disease (EVD) includes a fever of greater than 101.5 degrees Fahrenheit, and additional symptoms such as severe headache, muscle pain, vomiting, diarrhea, abdominal pain, or unexplained hemorrhage.

    Clinical criteria

    Clinical criteria for Ebola Virus Disease (EVD) includes a fever of greater than 101.5 degrees Fahrenheit, and additional symptoms such as severe headache, muscle pain, vomiting, diarrhea, abdominal pain, or unexplained hemorrhage.

Updated 10/6/14. Information courtesy of the U.S. Centers for Disease Control and Prevention. Compiled by Brianne Aiken, Hannah Dellabella, and Nicole Blazek.

Next hm-slideshow in Slides